Reducing expenditures for statin-type lipid-lowering agents.
D003363:Cost Control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000191:economics*; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000191:economics; D006949:Hyperlipidemias / Q000188:drug therapy / Q000191:economics*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000191:economics*; D008148:Lovastatin / Q000008:administration & dosage / Q000191:economics; D008329:Managed Care Programs / Q000191:economics; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008148:Lovastatin